What 'Research
Use Only'
Actually Means
'Research use only' means a material is supplied as a reference material for laboratory research, and is not a medicinal product. It is not a disclaimer bolted onto a consumer product — it is a description of what the material legally is. Under UK law an unlicensed compound cannot lawfully be advertised for human use, whatever wording appears alongside it.
A description, not a disclaimer
The phrase 'research use only' is widely treated as a formality — a line of small print added to a product that everyone involved understands to be something else. That reading is wrong, and it is wrong in a way that carries legal consequences for both supplier and purchaser.
Research use only is a description of what a material is. It denotes a compound supplied as a reference material for laboratory investigation, which holds no marketing authorisation, has not been assessed for safety or efficacy in humans, and is not a medicinal product. The designation is not a caveat attached to a consumer product. It is the category the material occupies.
Licensed medicines and unlicensed compounds
In the United Kingdom, a medicinal product requires a marketing authorisation before it can be placed on the market. Granting an authorisation is what the Medicines and Healthcare products Regulatory Agency (MHRA) does: it assesses evidence of quality, safety and efficacy, and if satisfied authorises the product for a defined indication.
A compound without that authorisation has not been through that assessment. Nobody has evaluated whether it is safe in humans, at what quantity, in what population, or with what interactions. The absence of an authorisation is not a paperwork gap — it is an absence of the evidence base that an authorisation represents.
The Human Medicines Regulations 2012 accordingly prohibit the advertising of a medicinal product that holds no marketing authorisation. This is why a compliant research supplier does not describe what a compound will do for a person: doing so would be advertising an unlicensed medicine, and the presence of a research-use line elsewhere on the page does not cure that.
Why the wording of product descriptions matters
A regulator assessing whether a product is being offered for human use does not stop at the disclaimer. It reads the whole presentation: the descriptions, the categories, the imagery, the surrounding marketing, the questions the seller answers.
A page that states 'research use only' while describing a compound in terms of the benefits a person would experience is not a research listing. The description carries the meaning, and the disclaimer contradicts rather than qualifies it. Product descriptions that identify what a compound is and the areas of scientific literature in which it has been studied are research descriptions. Descriptions promising an outcome in a person are not, whatever wording sits beneath them.
This is why our product listings describe compounds in the third person, in terms of what they are and where they appear in the literature, and never in terms of an effect on a reader.
What it requires of a purchaser
The designation places obligations on the buyer as well as the seller. Purchasing a research material means representing that it is being acquired for lawful research purposes, that it will not be administered to any human or animal, and that it will be handled, stored and disposed of appropriately by someone competent to do so.
Purchasers are also responsible for ensuring possession and use of a given material is lawful in their own jurisdiction. Legal status varies, and a compound freely supplied for research in one country may be controlled in another.
What a compliant supplier will not do
Some of the clearest signals of whether a supplier understands the category are the things it declines to do:
- Provide dosing information, administration protocols or cycle guidance — for any compound, on any request.
- Describe compounds in terms of outcomes for a person.
- Answer questions premised on human use.
- Present a certificate of analysis as though it were evidence of safety.
A supplier that will quietly advise on how to use a compound in a person is not treating the research designation as real, and the risk of that posture ultimately lands on the customer as much as on the business.
Our full position is set out in our Research Use Disclaimer. This article is general information about the regulatory landscape and is not legal advice.
Frequently Asked Questions
No. It is a description of what the material is: a reference material supplied for laboratory research that holds no marketing authorisation and has not been assessed for safety or efficacy in humans. It is not a caveat attached to a consumer product.
Under the Human Medicines Regulations 2012, advertising a medicinal product that holds no marketing authorisation is prohibited. Describing a compound in terms of the effects a person would experience constitutes advertising it for human use, regardless of any research-use wording elsewhere on the page.
Purchasing commits you to acquiring the material for lawful research purposes only, not administering it to any human or animal, handling and storing it appropriately, and ensuring that possession and use are lawful in your jurisdiction.
No. A certificate of analysis reports purity and identity for one batch. It is not an indication of safety, fitness for any purpose, or approval for use in humans or animals.